L. Kostakoglu et al., INFLUENCE OF THE HETEROGENEITY OF P-GLYCOPROTEIN EXPRESSION ON TECHNETIUM-99M-MIBI UPTAKE IN BREAST-CANCER, The Journal of nuclear medicine, 39(6), 1998, pp. 1021-1026
We prospectively studied a total of 30 patients with breast cancer to
evaluate the relationship between the degree of accumulation of (99m)-
sestamibi (MIBI) and the heterogeneity of p-glycoprotein expression in
tumor tissues. Methods: Twenty patients during initial presentation a
nd 10 patients during post-therapy evaluation underwent contemporaneou
s Tc-99m-MIBI imaging and surgery or biopsy. Immunohistochemical studi
es were performed on multiple nonconsecutive sections of the same tumo
r using a p-glycoprotein-specific monoclonal antibody, JSB-1. Tumor-to
-background (T/B) ratios were correlated with the level and heterogene
ity of p-glycoprotein expression determined by immunohistochemical stu
dies. Results: The T/B ratios were lower for those tumors with strong
p-glycoprotein expression (Group 1) than those with strong-to-weak exp
ression (Group 2) or those with weak-to-no expression (Group 3) (1.32
+/- 0.19 and 1.85 +/- 0.56 and 2.86 +/- 1.06, respectively). There was
statistically significant difference in T/B ratios between all 3 grou
ps (p < 0.005). Although T/B ratios for Group 1 and Group 3 were clear
ly distinct from one another with no overlapping values, the values fo
r Group 2 overlapped with those of Group I and Group 3. When we evalua
ted the entire patient group with excluding those with strong-to-weak
expression, although the p value remained the same (p < 0.001), we obt
ained a stronger correlation between T/B ratios and p-glycoprotein exp
ression (r = 0.808 versus 0.735). Conclusion: Due to the heterogeneous
expression of p-glycoprotein, both immunohistochemistry and Tc-99m-MI
BI scintigraphy may yield confounding results by contrasting with one
another if the presence or absence of p-glycoprotein is not extensivel
y explored. Although our data confirmed that Tc-99m-MIBI imaging is us
eful in the determination of the presence of multidrug resistance in p
atients with breast cancer, the issue of heterogeneous expression of t
he antigen should be further investigated when unexpected results are
obtained.